Related Experiment Video
Updated: Sep 28, 2025

09:57
18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography
Published on: January 11, 2020
7.6K
[18F]Difluorocarbene for positron emission tomography.
Jeroen B I Sap1, Claudio F Meyer1,2, Joseph Ford1
1University of Oxford, Chemistry Research Laboratory, Oxford, UK.
Nature
|March 28, 2022
Summary
Researchers developed a novel fluorine-18 difluorocarbene reagent for efficient radiolabeling. This breakthrough enables high-molar-activity difluoromethylation, crucial for pharmaceutical drug discovery and molecular imaging applications.
Area of Science:
- Nuclear imaging
- Radiochemistry
- Organic synthesis
Background:
- Total-body positron emission tomography (PET) expands molecular imaging research.
- Fluorine-18 (18F) radiochemistry has advanced, but 18F-difluoromethylation remains challenging.
- The difluoromethyl group is vital for pharmaceutical drug discovery.
Purpose of the Study:
- To introduce a general solution for 18F-difluoromethylation.
- To develop a versatile [18F]difluorocarbene reagent for nuclear imaging.
- To enable high molar activity labeling of difluoromethylated molecules.
Main Methods:
- Utilized carbene chemistry for nuclear imaging applications.
- Designed a novel [18F]difluorocarbene reagent for facile accessibility and high molar activity.
- Investigated isotopic dilution effects on precursor electronics.
- Demonstrated versatility through O-H, S-H, and N-H insertions, and cross-coupling reactions.
Main Results:
- Developed a general solution for 18F-difluoromethylation.
- Achieved high molar activity labeling.
- Showcased reagent versatility with various functional groups including (thio)phenols, N-heteroarenes, and aryl boronic acids.
- Successfully labeled complex, biologically relevant molecules and radiotracers.
Conclusions:
- The new [18F]difluorocarbene reagent overcomes previous limitations in 18F-difluoromethylation.
- This method provides facile access to high molar activity difluoromethylated compounds.
- The reagent's versatility and impact are demonstrated in labeling complex molecules for PET imaging and drug discovery.
More Related Videos
Related Concept Videos
Positron Emission Tomography
6.0K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.0K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
250
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
250

![Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F55537.jpg&w=3840&q=50)